JP2024543973A5 - - Google Patents
Info
- Publication number
- JP2024543973A5 JP2024543973A5 JP2024532491A JP2024532491A JP2024543973A5 JP 2024543973 A5 JP2024543973 A5 JP 2024543973A5 JP 2024532491 A JP2024532491 A JP 2024532491A JP 2024532491 A JP2024532491 A JP 2024532491A JP 2024543973 A5 JP2024543973 A5 JP 2024543973A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- alkyl
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284750P | 2021-12-01 | 2021-12-01 | |
| US63/284,750 | 2021-12-01 | ||
| PCT/US2022/051493 WO2023102100A1 (en) | 2021-12-01 | 2022-12-01 | Antagonists of the muscarinic acetylcholine receptor m4 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543973A JP2024543973A (ja) | 2024-11-26 |
| JP2024543973A5 true JP2024543973A5 (https=) | 2025-12-08 |
Family
ID=84943708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532491A Pending JP2024543973A (ja) | 2021-12-01 | 2022-12-01 | ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250145595A1 (https=) |
| EP (1) | EP4441046A1 (https=) |
| JP (1) | JP2024543973A (https=) |
| KR (1) | KR20240112343A (https=) |
| CN (2) | CN116669737A (https=) |
| AU (1) | AU2022400780A1 (https=) |
| CA (1) | CA3241298A1 (https=) |
| IL (1) | IL313219A (https=) |
| MX (1) | MX2024006718A (https=) |
| WO (1) | WO2023102100A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018300980A1 (en) | 2017-07-12 | 2020-01-02 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor M4 |
| IL273924B2 (en) | 2017-10-20 | 2024-07-01 | Univ Vanderbilt | Antagonists of the muscarinic acetylcholine receptor m4 |
| CA3155864A1 (en) | 2019-10-04 | 2021-04-08 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
| EP4491228A3 (en) * | 2020-12-22 | 2025-04-23 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018003417B1 (pt) * | 2016-06-22 | 2023-10-24 | Vanderbilt University | Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende |
| JP2020530451A (ja) * | 2017-08-08 | 2020-10-22 | ヴァンダービルト ユニバーシティー | ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト |
| IL273924B2 (en) * | 2017-10-20 | 2024-07-01 | Univ Vanderbilt | Antagonists of the muscarinic acetylcholine receptor m4 |
| WO2021119254A1 (en) * | 2019-12-10 | 2021-06-17 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
| US20230183218A1 (en) * | 2020-04-24 | 2023-06-15 | Vanderbilt University | Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4 |
| EP4139303A1 (en) * | 2020-04-24 | 2023-03-01 | Vanderbilt University | Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4 |
-
2021
- 2021-12-22 CN CN202180087480.8A patent/CN116669737A/zh active Pending
-
2022
- 2022-12-01 AU AU2022400780A patent/AU2022400780A1/en active Pending
- 2022-12-01 EP EP22843543.4A patent/EP4441046A1/en active Pending
- 2022-12-01 CA CA3241298A patent/CA3241298A1/en active Pending
- 2022-12-01 JP JP2024532491A patent/JP2024543973A/ja active Pending
- 2022-12-01 KR KR1020247021498A patent/KR20240112343A/ko active Pending
- 2022-12-01 IL IL313219A patent/IL313219A/en unknown
- 2022-12-01 US US18/715,048 patent/US20250145595A1/en active Pending
- 2022-12-01 MX MX2024006718A patent/MX2024006718A/es unknown
- 2022-12-01 WO PCT/US2022/051493 patent/WO2023102100A1/en not_active Ceased
- 2022-12-01 CN CN202280088712.6A patent/CN118541365A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024543973A5 (https=) | ||
| CN1057087C (zh) | 取代的噁嗪和噻嗪噁唑烷酮抗微生物剂 | |
| EP4408832A1 (en) | Novel prodrugs of mdma, mda, and derivatives thereof | |
| JP2022126779A (ja) | オキサジアゾール一過性受容器電位チャネル阻害剤 | |
| JP2006513268A5 (ja) | アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体 | |
| NO20072833L (no) | Bi- og tricykliske substituterte fenylmetanoner som glycinetransportor I-(Glyt-1)-inhibitorer for behandling av Alzheimers sykdom | |
| JP2022550459A5 (https=) | ||
| US11912680B2 (en) | Nitric oxide releasing prodrugs of MDA and MDMA | |
| JP2024508545A5 (https=) | ||
| JP2018523665A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| JP2021512109A5 (https=) | ||
| JP2007512283A5 (https=) | ||
| RU2008100019A (ru) | Способ лечения чрезмерной дневной сонливости (варианты) | |
| JP2022534704A5 (https=) | ||
| JP2024508922A5 (https=) | ||
| JP2021522262A5 (https=) | ||
| JP2022534709A5 (https=) | ||
| JP2018520202A5 (https=) | ||
| JP2021534099A (ja) | 神経変性疾患を治療するためのＰｐａｒｇｃ１ａ活性化剤としての２‐アリールベンゾイミダゾール | |
| JP2023532985A5 (https=) | ||
| JP2024546678A5 (https=) | ||
| JP6911033B2 (ja) | 極性非プロトン性溶媒を用いたｎ−［４−（１−アミノエチル）−フェニル］−スルホンアミド誘導体のキラル分割方法 | |
| RU2006124513A (ru) | Производные бензоксазина и их применение | |
| CN101525316A (zh) | 喹啉类衍生物及其制备方法和用途 |